Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cetuximab Products

(Cetuximab)

Categories

antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.

Recommended Cetuximab Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application ELISA
Validations
Cat. No. ABIN7514458
Quantity 40 μg
Datasheet Datasheet
Reactivity Human
Application ELISA, BP
Validations
Cat. No. ABIN7514457
Quantity 40 μg
Datasheet Datasheet
Reactivity Human
Application ELISA, BP
Validations
Cat. No. ABIN7514416
Quantity 40 μg
Datasheet Datasheet

Recommended Cetuximab ELISA Kits

Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human, Mouse, Rat
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
  • (1)
Cat. No. ABIN4886391
Quantity 96 tests
Datasheet Datasheet

Latest Publications for our Cetuximab products

van Helden, Elias, Gerritse, van Es, Boon, Huisman, van Grieken, Dekker, van Dongen, Vugts, Boellaard, van Herpen, de Vries, Oyen, Brouwers, Verheul, Hoekstra, Menke-van der Houven van Oordt: "[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer." in: European journal of nuclear medicine and molecular imaging, Vol. 47, Issue 4, pp. 849-859, (2021) (PubMed).

Shibata, Naito, Okamura, Hosokawa, Mineta, Kawakami: "Simple and rapid LC-MS/MS method for the absolute determination of cetuximab in human serum using an immobilized trypsin." in: Journal of pharmaceutical and biomedical analysis, Vol. 146, pp. 266-272, (2018) (PubMed).

Bálint, Rutka, Végh, Kürti, Gecse, Banai, Bene, Gasztonyi, Kristóf, Lakatos, Miheller, Palatka, Patai, Salamon, Szamosi, Szepes, Tóth, Vincze, Bor, Milassin, Fábián, Nagy, Kolar, Bortlik, Duricova et al.: "Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. ..." in: Expert opinion on drug safety, Vol. 16, Issue 8, pp. 885-890, (2017) (PubMed).

You are here:
Support